B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet finished but already full! 1 Terminated 1

CRISPR cancer therapy trial halted: what happened with CTX110?

Disease control Terminated

This study tested a one-time treatment using CRISPR-edited immune cells from a donor (CTX110) in 93 adults with B-cell cancers like lymphoma or leukemia that had come back or stopped responding to other treatments. The goal was to see if these cells were safe and could shrink tum…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

CRISPR cancer therapy trial halted: what happened with CTX110?